Skip to main content
. 2016 Nov 7;58(1):90–98. doi: 10.3349/ymj.2017.58.1.90

Table 4. Angiographic Characteristics between the Two Groups.

Variables, n (%) Entire patients Matched patients
Diltiazem (n=842) Dual (n=1899) p value Diltiazem (n=811) Dual (n=811) p value
Quantitative coronary angiography
 MLD (mm) 0.6±0.3 0.7±0.3 0.452 0.6±0.3 0.6±0.3 0.440
 Diameter narrowing (%) 70.3±12.4 70.7±13.0 0.494 70.4±12.5 71.3±12.7 0.144
 RVD (mm) 2.3±0.9 2.4±0.5 0.096 2.3±0.9 2.3±0.5 0.855
Acetylcholine dose
 A1 (20 ug) 41 (4.8) 109 (5.7) 0.354 41 (5.0) 55 (6.7) 0.141
 A2 (50 ug) 268 (31.8) 689 (36.3) 0.023 263 (32.4) 273 (33.6) 0.598
 A3 (100 ug) 533 (63.3) 1100 (57.9) 0.009 507 (62.5) 483 (59.5) 0.222
Spasm site 2 (0.2) 4 (0.2) NS 2 (0.2) 2 (0.2) 1.000
 Left arterial descending 799 (94.8) 1778 (93.6) 0.198 768 (94.6) 772 (95.1) 0.650
 Left circumflex 274 (32.5) 762 (40.1) <0.001 271 (33.4) 275 (33.9) 0.834
Spasm location 3 (0.3) 8 (0.4) NS 3 (0.3) 2 (0.2) 1.000
 Proximal 380 (45.1) 929 (48.9) 0.067 366 (45.1) 365 (45) 0.960
 Mid 771 (91.5) 1721 (90.6) 0.429 743 (91.6) 736 (90.7) 0.540
 Distal 684 (81.2) 1547 (81.4) 0.887 661 (81.5) 656 (80.8) 0.751
Diffuse spasm* 723 (85.8) 1632 (85.9) 0.960 697 (85.9) 698 (86.0) 0.943
Multi-vessel spasm 235 (27.9) 665 (35) <0.001 232 (28.6) 246 (30.3) 0.446
EKG change 41 (4.8) 119 (6.2) 0.150 40 (4.9) 34 (4.1) 0.475
 ST-segment elevation 12 (1.4) 42 (2.2) 0.172 12 (1.4) 11 (1.3) 0.834
 ST-segment depression 11 (1.3) 47 (2.4) 0.050 11 (1.3) 12 (1.4) 0.834
 T-inversion 10 (1.1) 20 (1.0) 0.755 10 (1.2) 5 (0.6) 0.195
Atrial fibrillation 8 (0.9) 10 (0.5) 0.205 7 (0.8) 6 (0.7) 0.781
Chest pain 534 (63.4) 1274 (67) 0.062 521 (64.2) 503 (62.0) 0.354
AV block 285 (33.8) 388 (20.4) <0.001 276 (34.0) 179 (22.0) <0.001

MLD, minimum luminal diameter (during acetylcholine provocation test); RVD, reference vessel diameter (after nitroglycerin injection); EKG, echocardiogram; AV, atrioventricular.

*Narrowing length >30 mm.